Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-10
2011-05-10
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S256000, C514S341000, C514S392000, C540S553000, C540S492000, C544S315000, C546S274400, C548S316400
Reexamination Certificate
active
07939523
ABSTRACT:
Imidazolidinone and imidazolinethione compounds of formula (I):wherein R1, R2, R3, A1, A2, X, Y, Z, m, n, p, x, and y are defined herein. Also disclosed is a method of treating hepatitis C virus infection with these compounds.
REFERENCES:
patent: 4221817 (1980-09-01), Tenne
patent: 6521614 (2003-02-01), Maduskuie et al.
patent: 6696487 (2004-02-01), Gerusz et al.
patent: 7094807 (2006-08-01), Chen et al.
patent: 7102007 (2006-09-01), Aebi et al.
patent: 2005/0032849 (2005-02-01), Phadke et al.
patent: 2005/0228013 (2005-10-01), Thurkauf et al.
patent: 2006/0025416 (2006-02-01), Phadke et al.
patent: 2005/330284 (2005-02-01), None
patent: 2005/144790 (2005-05-01), None
patent: WO 99/40088 (1999-08-01), None
patent: WO2004/046095 (2004-06-01), None
patent: WO 2004052852 (2004-06-01), None
patent: WO2004/096210 (2004-11-01), None
patent: WO2005/095345 (2005-10-01), None
patent: WO2006/122011 (2006-11-01), None
patent: WO 2007065939 (2007-06-01), None
Cory et al., “Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in Culture,”Cancer Communications, vol. 3, No. 7, (1991).
Honda et al., Chem. Abst. 135 357776 (2001).
Willson et al. Chem. Abst. 118: 212577 (1993).
Bennett et al., J. Am Chem Soc. 1953 75(23); 6039-6040.
Chao Yu-Sheng
Chern Jyh-Haur
Hsu Sheng-Ju
Hsu Tsu-An
Kang Iou-Jiun
Barker Michael
Chu Yong
National Health Research Institutes
Occhiuti Rohlicek & Tsao LLP
LandOfFree
Imidazolidinone and imidazolidinethione derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolidinone and imidazolidinethione derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolidinone and imidazolidinethione derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2686309